<?xml version="1.0" encoding="UTF-8"?>
<p>Viral genotypes affect the response to interferon therapy. The sustained virologic response to pegylated interferon plus ribavirin ranges from about 40 to 50 percent with genotype 1 (including 1a and 1b) to as high as 70–80 % with genotypes 2 and 3 [
 <xref ref-type="bibr" rid="CR131">131</xref>–
 <xref ref-type="bibr" rid="CR136">136</xref>].
</p>
